Clinical Report: Development and Validation of a Nomogram Model for Cervical Cancer

Overview

This study presents a novel nomogram model for prognostic assessment in patients with primary cervical squamous cell carcinoma and elevated serum SCC antigen levels (≥10 ng/mL). The model integrates inflammatory biomarkers and clinical variables to enhance individualized risk assessment and guide treatment decisions.

Background

Incorporate statistics or references to substantiate claims about cervical cancer morbidity and mortality.

Data Highlights

No numerical data available in the provided source material.

Key Findings

• High pretreatment SCC-Ag levels (≥10 ng/mL) are associated with increased tumor aggressiveness and recurrence risk.
• Systemic inflammatory markers such as NLR, PLR, and SII correlate with survival outcomes in cervical cancer.
• Hematological parameters like HRR and RDW may indicate prognosis and treatment response.
• The proposed nomogram model effectively integrates these factors for individualized risk assessment.
• Existing prognostic models do not adequately address the specific needs of patients with elevated SCC-Ag levels.

Clinical Implications

Healthcare professionals should consider utilizing the developed nomogram model to better stratify patients with high SCC-Ag levels, thereby facilitating tailored treatment approaches. Incorporating inflammatory biomarkers into clinical practice may enhance prognostic accuracy and improve patient outcomes.

Conclusion

The development of a nomogram model for patients with primary cervical cancer and elevated SCC-Ag levels represents a significant advancement in personalized cancer care. This model aims to improve prognostic assessments and guide clinical decision-making effectively.

References

1. University of Arizona, NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer, Version 2.2026
2. Systemic immune-inflammatory index for the prediction of the survival in patients with cervical cancer: a meta-analysis, ScienceDirect
3. A novel nomogram utilizing log odds of positive lymph nodes to forecast overall survival in colorectal signet ring cell carcinoma patients: Insights from a SEER population-based analysis
4. Evaluating the Prognostic Significance of Standard Blood Biomarkers for Three-Year Survival in Patients with Resectable Colorectal Cancer: A Clinical Nomogram Approach
5. Survival Prediction Model for Early-Onset Colorectal Cancer Patients: Insights from a Population-Based Study
6. Creation and assessment of a nomogram for predicting overall survival in young patients with non-metastatic rectal cancer following curative surgery: a population-based study
7. The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023)
8. NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY: Cervical Cancer, Version 2.2026 - University of Arizona
9. Systemic immune-inflammatory index for the prediction of the survival in patients with cervical cancer: a meta-analysis - ScienceDirect